A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

Clinical trial NCT07063212 · RECRUITING

Trial details

NCT number: NCT07063212
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck Sinus Cancer Nasal Cavity Cancer Oral Cavity Cancer Oropharynx Cancer Hypopharynx Cancer Larynx Cancer Oral Squamous Cell Carcinoma Oropharynx Squamous Cell Carcinoma Hypopharynx Squamous Cell Carcinoma Larynx Squamous Cell Carcinoma HPV Positive Oropharyngeal Squamous Cell Carcinoma

Start date: 2025-07-02
Primary completion: 2028-01-02
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.